Quanex Building Products (NX) Q3 Sales Rise 1.3% to $501.8M, Returns to Profitability
Quanex Building Products reported Q3 fiscal 2026 sales of $501.8 million, up 1.3% year-over-year, with adjusted EPS increasing to $0.79 from $0.69. The company returned to profitability with a net income of $26.5 million, compared to a net loss of $276 million in the prior year (largely due to a goodwill impairment). Adjusted EBITDA reached $72.7 million. Management expects modest Q4 revenue growth of 2%-3% and adjusted EBITDA margin expansion of 50-75 basis points, despite an uneven housing market and ongoing cost pressures. Quanex also repaid $42.25 million of debt during the quarter, reducing its leverage ratio to 2.8 times.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Oracle, Meta, and SpaceX credit default swaps (CDS) hit all-time highs, as the market anticipates a surge in AI-related bond issuance in Q4.
-
2
Liu Jun, President of Industrial and Commercial Bank of China (ICBC): Commercial Banks Bear Heavier Financial and Legal Responsibilities Than Central Banks in AI Deployment
-
3
Bain Survey: Chinese Consumers Prioritize Technology in Car Purchases, While Europeans and Americans Still Value Price; Western Automakers Face Dual Pressure
-
4
Anthropic pitches AI safety bill that would require judge's permission to block models
-
5
Anthropic reportedly faces a compute shortage as cloud giants view it as a competitor, plans November IPO.
-
6
NextDC's data center project in Australia faces power supply delays due to resident protests, leading to a more than one-third reduction in its FY2027 earnings guidance and a 45% plunge in its stock price.
-
7
Media reports: Amazon Web Services (AWS) has billions of dollars worth of NVIDIA chips backlogged in its warehouses due to power shortages, leading to negative free cash flow.
-
8
Hansoh Pharmaceutical inks up to $15B drug deal with Roche, China's innovative drug out-licensing hits $130B
-
9
U.S. equity index futures rose, boosted by strong earnings reports from AI-related companies.
-
10
King Charles III of the UK praised Oman's peaceful efforts in reopening the Strait of Hormuz.
Markets Today
Recommended Reading


